Molecular genetic analysis of haematological malignancies: I. Acute leukaemias and myeloproliferative disorders
AJ Bench, WN Erber, MA Scott - Clinical & Laboratory …, 2005 - Wiley Online Library
Molecular genetic techniques are now routinely applied to haematological malignancies
within a clinical laboratory setting. The detection of genetic rearrangements not only assists …
within a clinical laboratory setting. The detection of genetic rearrangements not only assists …
STI571 and morpholine derivative of doxorubicin collaborate in inhibition of K562 cell proliferation by inducing differentiation and mitochondrial pathway of apoptosis
J Jakubowska, M Wasowska-Lukawska… - European journal of …, 2008 - Elsevier
Differentiation therapy is considered as a supplementary approach to the currently applied
treatments for leukemia. We have previously shown that a morpholine derivative of …
treatments for leukemia. We have previously shown that a morpholine derivative of …
Molecular measurement of BCR-ABL transcript variations in chronic myeloid leukemia patients in cytogenetic remission
M Serpa, SS Sanabani, PE Dorliac-Llacer, M Conchon… - BMC Hematology, 2010 - Springer
Background The monitoring of BCR-ABL transcript levels by real-time quantitative
polymerase chain reaction (RT-qPCR) has become important to assess minimal residual …
polymerase chain reaction (RT-qPCR) has become important to assess minimal residual …
New computational tools for modeling chronic myelogenous leukemia
In this paper, we consider a system of nonlinear delay-differential equations (DDEs) which
models the dynamics of the interaction between chronic myelogenous leukemia (CML) …
models the dynamics of the interaction between chronic myelogenous leukemia (CML) …
Peripheral blood vs. bone marrow for molecular monitoring of BCR‐ABL1 levels in chronic myelogenous leukemia, a retrospective analysis in allogeneic bone …
A Ballestrero, G Cirmena, A Dominietto… - International Journal …, 2010 - Wiley Online Library
Molecular monitoring of the BCR‐ABL1 transcript in chronic myelogenous leukemia (CML)
using quantitative real‐time PCR (RQ‐PCR) can be performed using either bone marrow …
using quantitative real‐time PCR (RQ‐PCR) can be performed using either bone marrow …
First-line therapy for chronic myeloid leukemia: new horizons and an update
G Saglio, M Baccarani - Clinical Lymphoma Myeloma and Leukemia, 2010 - Elsevier
Although imatinib has shown unprecedented efficacy in the treatment of newly diagnosed
chronic-phase chronic myeloid leukemia (CP-CML), approximately one third of patients …
chronic-phase chronic myeloid leukemia (CP-CML), approximately one third of patients …
Молекулярный мониторинг у пациентов с хроническим миелолейкозом: корреляция с цитогенетическим ответом, прогностическое значение, оценка ответа …
ЕВ Аксенова, АА Крутов, ИН Солдатова… - Клиническая …, 2010 - cyberleninka.ru
Молекулярный мониторинг экспрессии BCR-ABL обязательный атрибут контроля
лечения хронического миелолейкоза. Достижение большого молекулярного ответа …
лечения хронического миелолейкоза. Достижение большого молекулярного ответа …
Current practices in the management of chronic myeloid leukemia
HM Kantarjian, RA Larson, JE Cortés… - … Myeloma and Leukemia, 2013 - Elsevier
Background A previous survey of physician self-reported practice patterns in the
management of CML was conducted in 2005. The National Comprehensive Cancer Network …
management of CML was conducted in 2005. The National Comprehensive Cancer Network …